
Hypr View is revolutionizing biomedical and pharmaceutical research with a cutting-edge microscopy platform that enhances predictive classification models in digital pathology. Their unique technology integrates various microscopy imaging modalities, significantly improving dataset quality and elevating computational model accuracy. By providing a comprehensive view of biological samples, Hypr View's multimodal approach transforms biological sample characterization, enabling precise identification of cellular structures, patterns, and biomarkers. This innovation paves the way for breakthroughs in disease diagnosis, drug development, and personalized medicine, while also offering tailored AI solutions for data analysis to meet unique laboratory needs.

Hypr View is revolutionizing biomedical and pharmaceutical research with a cutting-edge microscopy platform that enhances predictive classification models in digital pathology. Their unique technology integrates various microscopy imaging modalities, significantly improving dataset quality and elevating computational model accuracy. By providing a comprehensive view of biological samples, Hypr View's multimodal approach transforms biological sample characterization, enabling precise identification of cellular structures, patterns, and biomarkers. This innovation paves the way for breakthroughs in disease diagnosis, drug development, and personalized medicine, while also offering tailored AI solutions for data analysis to meet unique laboratory needs.
Founded: 2021
Headquarters: Caen, Basse-Normandie, France
Sector: Biotechnology / IT — multimodal imaging & data processing
Size: 1–10 employees
Funding: Non-equity assistance from Normandie Incubation
Biomedical and pharmaceutical research, digital pathology, dataset quality for machine learning
2021
Biotechnology